PD. Dr. med. Thomas Neumann
Rheumatologie · Dept. I
Retinale endotheliale Dysfunktion bei Raynaud-Phänomen
Jun 1, 2022Untersuchung der Endothelfunktion retinaler Gefässe bei Patienten mit einem Raynaud Phänomen mit dem Ziel, Veränderungen im Vergleich zu gesunden Menschen darzustellen und Beziehungen zwischen Parametern der retinalen Endothelfunktion, der Kapillarmi...
Clinical Studies - Jun 1, 2022 - Jun 30, 2025
Ongoing
Project leader: Neumann Thomas
Members: Todorova Margarita, Güsewell Sabine
IFX-1-P2.5
Nov 1, 2020a randomized, double-blind, double-dummy, active-controlled, multicenter, 2-part Phase 2 study on replacement of steroids by IFX-1 in active granulomatosis with polyangiitis (GPA) and microscopic polyangitis (MPA)
Clinical Studies - Nov 1, 2020 - Nov 1, 2021
Completed
Project leader: Neumann Thomas
Members: Peischl Riana, Rubbert-Roth Andrea
RA Bridge
Oct 3, 2019A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients with Rheumatoid Arthritis
Clinical Studies - Oct 3, 2019 - Jul 30, 2023
Automatically Closed
Project leader: Rubbert-Roth Andrea
Members: Bartz-Batliner Mira, Neumann Thomas, Sasselli Clelia, Peischl Riana
Amgen CC-10004-PsA-014 MOSAIK
Jul 31, 2019A PHASE 4, MULTICENTER, SINGLE-ARM, OPENLABEL STUDY TO EVALUATE THE IMPACT OF APREMILAST (CC-10004) ON MRI OUTCOMES IN SUBJECTS WITH PSORIATIC ARTHRITIS
Clinical Studies - Jul 31, 2019 - Aug 31, 2021
Completed
Project leader: Rubbert-Roth Andrea
Members: Bartz-Batliner Mira, Neumann Thomas, Sasselli Clelia, Peischl Riana
Sanofi PMR EFC15160
Jul 4, 2019A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with polymyalgia rheumatica
Clinical Studies - Jul 4, 2019 - Jul 8, 2021
Automatically Closed
Project leader: Rubbert-Roth Andrea
Members: Neumann Thomas, Bartz-Batliner Mira, Peischl Riana, Sasselli Clelia
Sanofi GCA EFC15068
Jul 4, 2019A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis
Clinical Studies - Jul 4, 2019 - Jul 8, 2020
Aborted
Project leader: Rubbert-Roth Andrea
Members: Neumann Thomas, Bartz-Batliner Mira, Peischl Riana, Sasselli Clelia
Abbvie M16-852 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and
Apr 2, 2019Giant Cell Arteritis: Phase 3 Safety and Efficacy Study of Upadacitinib in Subjects with Giant Cell Arteritis
Clinical Studies - Apr 2, 2019 - Dec 31, 2024
Ongoing
Project leader: Rubbert-Roth Andrea
Members: Hutz Carina Liane, Bartz-Batliner Mira, Neumann Thomas, Peischl Riana, Sasselli Clelia
Lilly JAHZ A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib
Feb 28, 2019A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients with systemic lupus erythematosus (SLE).
Clinical Studies - Feb 28, 2019 - Feb 28, 2022
Completed
Project leader: Rubbert-Roth Andrea
Members: Neumann Thomas, Bartz-Batliner Mira, Hutz Carina Liane, Peischl Riana, Sasselli Clelia
CORBUS: Lenabasum bei diffuser systemischer Sklerose
Sep 25, 2018A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Clinical Studies - Sep 25, 2018 - Sep 27, 2021
Aborted
Project leader: Rubbert-Roth Andrea
Members: Hutz Carina Liane, Bartz-Batliner Mira, Neumann Thomas
Abbvie M15-925: A Phase 3, Randomized, Active-Controlled,
Aug 15, 2018
Clinical Studies - Aug 15, 2018 - Aug 16, 2024
Completed
Project leader: Hutz Carina Liane, Rubbert-Roth Andrea
Members: Bartz-Batliner Mira, Neumann Thomas
Lilly RHCF SPIRIT
Oct 16, 2017A 52-Week Multicenter, Randomized, Open-Label, Parallel- Group Study Evaluating the Efficacy and Safety of Ixekizumab versus Adalimumab in Patients with Psoriatic Arthritis Who Are Biologic Disease-Modifying Anti-Rheumatic Drug Naive
Clinical Studies - Oct 16, 2017 - Oct 24, 2021
Completed
Project leader: Rubbert-Roth Andrea
Members: Bartz-Batliner Mira, Forrer Silvia, Hutz Carina Liane, Neumann Thomas
Abbvie M15-572 Phase 3 PsA mit inadäquater Response auf bDMARD
Oct 2, 2017A Phase 3, Randomized, Double-Blind, Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Subjects with Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumat...
Clinical Studies - Oct 2, 2017 - Oct 3, 2024
Automatically Closed
Project leader: Rubbert-Roth Andrea
Members: Bartz-Batliner Mira, Hutz Carina Liane, Neumann Thomas
CCX_Chemocentryx CL010 CCX168 (Avacopan)
May 15, 2017A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CCX168 (Avacopan) in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)- Associated Vasculitis Treated Concomitantly with Rituximab or Cycloph...
Clinical Studies - May 15, 2017 - May 31, 2021
Completed
Project leader: Neumann Thomas
Members: Forrer Silvia, Hutz Carina Liane, Bartz-Batliner Mira, Rubbert-Roth Andrea
Arthritis check up: Evaluation einer Strategie zur Früherkennung der Rheumatoider Arthritis
Sep 16, 2009Bei der rheumatoiden Arthritis (RA) handelt es sich um eine als Syndrom definierte Entität, deren Ätiologie und Pathogenese nur unvollständig verstanden ist. Das Risiko für das Auftreten einer RA ist im familiären Kontext erhöht. Neben einer genetisc...
Fundamental Research - Sep 16, 2009 - Nov 30, 2024
Ongoing
Project leader: Rubbert-Roth Andrea
Members: Bartz-Batliner Mira, Hutz Carina Liane, Neumann Thomas, Peischl Riana, Sasselli Clelia